Kyrgyzstan
Diabetes country report 2000 — 2050
Number of adults (20–79 years) with diabetes in Kyrgyzstan (KG)
2000 | 93.0 thousand |
2011 | 154.2 thousand |
2024 | 263.1 thousand |
2050 | 412.8 thousand |
Kyrgystan is one of the 60 countries and territories in the IDF Europe Region.
Data source(s) used for the diabetes estimates in adults:
- Estimates extrapolated from Turkmenistan and Uzbekistan.
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 93.0 | 154.2 | 263.1 | 412.8 |
Age-standardised prevalence of diabetes, % | - | 6.3 | 7.6 | 7.6 |
Proportion of people with undiagnosed diabetes, % | - | - | 56.7 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 149.3 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 155.7 | 217.2 |
Age-standardised prevalence of IFG, % | - | - | 4.4 | 3.9 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 147.3 | 116.4 | 219.7 |
Age-standardised prevalence of IGT, % | - | 5.9 | 3.7 | 4.3 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 2,514.0 | 1,779.4 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 5.6 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 60.9 | 88.6 |
Total diabetes-related health expenditure, ID million | - | - | 184.7 | 268.5 |
Diabetes-related health expenditure per person, USD | - | 79.0 | 231.5 | 214.6 |
Diabetes-related health expenditure per person, ID | - | - | 702.0 | 650.5 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 2,557.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 947.0 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 2,537.0 | 3,142.1 | 3,885.9 | 6,045.9 |
Population of children and adolescents (0-19 y) | - | - | 2,934,659.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 93.0 |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 2,537.0 |
Population of children and adolescents (0-19 y) | - |